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Open Access

Genome-wide identification of allele-specific
expression (ASE) in response to Marek’s disease
virus infection using next generation sequencing
Sean MacEachern1,2, William M Muir3, Seth Crosby4, Hans H Cheng1*
From International Symposium on Animal Genomics for Animal Health (AGAH 2010)
Paris, France. 31 May – 2 June 2010
Abstract
Background: Marek’s disease (MD), a T cell lymphoma induced by the highly oncogenic a-herpesvirus Marek’s
disease virus (MDV), is the main chronic infectious disease concern threatening the poultry industry. Enhancing
genetic resistance to MD in commercial poultry is an attractive method to augment MD vaccines, which is
currently the control method of choice. In order to optimally implement this control strategy through markerassisted selection (MAS) and to gain biological information, it is necessary to identify specific genes that influence
MD incidence.
Methods: A genome-wide screen for allele-specific expression (ASE) in response to MDV infection was conducted.
The highly inbred ADOL chicken lines 6 (MD resistant) and 7 (MD susceptible) were inter-mated in reciprocal
crosses and half of the progeny challenged with MDV. Splenic RNA pools at a single time after infection for each
treatment group point were generated, sequenced using a next generation sequencer, then analyzed for allelespecific expression (ASE). To validate and extend the results, Illumina GoldenGate assays for selected cSNPs were
developed and used on all RNA samples from all 6 time points following MDV challenge.
Results: RNA sequencing resulted in 11-13+ million mappable reads per treatment group, 1.7+ Gb total sequence,
and 22,655 high-confidence cSNPs. Analysis of these cSNPs revealed that 5360 cSNPs in 3773 genes exhibited
statistically significant allelic imbalance. Of the 1536 GoldenGate assays, 1465 were successfully scored with all but
19 exhibiting evidence for allelic imbalance.
Conclusions: ASE is an efficient method to identify potentially all or most of the genes influencing this complex
trait. The identified cSNPs can be further evaluated in resource populations to determine their allelic direction and
size of effect on genetic resistance to MD as well as being directly implemented in genomic selection programs.
The described method, although demonstrated in inbred chicken lines, is applicable to all traits in any diploid
species, and should prove to be a simple method to identify the majority of genes controlling any complex trait.

Background
The comprehensive identification of genes underlying
phenotypic variation of complex traits such as disease
resistance remains one of the greatest challenges in biology despite having genome sequences and more powerful tools. Most genome-wide screens lack sufficient
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resolving power as they typically depend on linkage. An
alternate method is to screen for allele-specific expression (ASE), a simple yet powerful approach, where the
expression of each gene allele is compared within an
RNA sample. When the expression of the alleles is not
equal, then one can unequivocally declare ASE and the
presence of a polymorphic cis-acting (genetic) element
for that gene as linkage disequilibrium (LD) is confined
to the transcriptional unit. The only requirements for
ASE to work are: (1) the assumption that variations in
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expression between alleles of a gene are responsible for
part of the phenotypic variation, and (2) the existence of
a cSNP to monitor the alleles. In this proof-of-concept
study, a genome-wide screen for ASE in response to
MDV infection in chicken was conducted using next
generation sequencing to identify cSNPs and preliminary
evidence for allelic imbalance followed by validation
with Illumina Illumina GoldenGate assays to validate.

Methods
Generation of samples

The highly inbred ADOL chicken lines 6 (MD resistant)
and 7 (MD susceptible) were inter-mated in reciprocal
crosses. Half of the progeny in each cross were challenged with MDV (2,000 pfu JM strain) at 2 weeks of
age. At 1, 4, 7, 11, 13, and 15 days post-infection (dpi),
12 birds per treatment group were terminated; pure line
birds were similarly treated with 14 birds per treatment
group. RNA from spleen was isolated and quantified.
RNA sequencing and analysis

Two pools containing equal amounts of RNA from 6
birds each per treatment group at 4 dpi were generated,
then sequenced using an Illumina GA. Using the Maq
algorithm [1] to align the reads and a custom Python
script, SNPs were detected, then filtered for sequence
quality and alignment depth. Allelic imbalance was
determined using a chi-square test (p<0.05).
Validation using Illumina GoldenGate assays and analysis

Based primarily on Illumina design scores, assays for
1536 selected cSNPs were developed and used on RNA
samples of all F 1 birds. In addition, artificial F 1 pools
generated by mixing equal amounts of RNA from each
pure line were screened to query for the influence of
trans-acting factors; 12 line 6x7 F1 and 12 line 7x6 F1
DNAs were also measured to normalize the assays. The
dataset was analyzed using linear models.
Relative influence of cis- and trans-acting factors

True vs. artificial F1 expression ratios were plotted for
each time point and condition for splenic RNAs. The
total percentage of each SNP effect was estimated and
the averages plotted over the course of infection.
Pathways analysis
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(3) time after infection, (4) different tissues, and (5)
trans-acting factors via artificial F1 pools. As a result, we
had 288 F1 samples and 168 artificial F1 RNA pools.
For ASE assays, it is necessary to have a cSNP for
each allele within each gene; the polymorphism does
not have to be nonsynonymous and can be in the 3’
UTR. Thus, to get a genome-wide and unbiased survey
of all the expressed genes and an indication of ASE,
replicate RNA pools from a single time point (4 dpi)
were sequenced using a next generation sequencer. This
resulted in 11-13+ million mappable reads per treatment
group, 1.7+ Gb surveyed, and after filtering, 22,655
high-confidence cSNPs. Analysis of these cSNPs
revealed that 5360 cSNPs in 3773 genes exhibited statistically significant allelic imbalance.
To economically validate and extend the results, 1536
cSNPs exhibiting ASE were screened on all the RNA
samples of all F 1 birds using Illumina GoldenGate
arrays. In addition, artificial F1 pools generated by mixing equal amounts of RNA from each pure line were
screened to query for the influence of trans-acting factors. The initial statistical analysis of 1465 functioning
assays for ASE effects is shown in Table 1.
Besides finding genes with cis-regulatory element, the
relative influence of trans-acting factors for each gene
can be quantified by plotting the relative expression of
each allele in true vs. artificial F1 RNAs as described by
Wittkopp et al.[2]. Furthermore, the data can be further
analyzed like microarrays to identify pathways that are
enriched for ASE. Using the Metacore (GeneGo) database, T cell activation, vesicle mediated transport, and
cell cycling were identified.

Conclusions
Using our protocol of RNA seq followed by confirmation using Illumina GoldenGate arrays, we have identified a large number of genes exhibiting ASE in response
to MDV infection. Furthermore, the direction of the
cross also influences ASE, which suggests maternal or
epigenetic influences. Undoubtedly, many of these genes
contribute to genetic resistance to MD, which can be
Table 1 Number of SNPs with significant sources of
variation affect ASE
Source of variation

No. of significant SNPs

Biological processes were screened by inputting genes
exhibiting ASE in response to MDV infection into the
Metacore (GeneGo) database.

Direction of cross (CROSS)
Infection (INF)

481
1040

Days post infection (DPI)

1417

INF x DPI

1407

Results and discussion
RNAs from parental lines or F1 progeny were obtained
to evaluate potential influence of (1) maternal or epigenetic effects via reciprocal matings, (2) MDV infection,

INF x CROSS

14

DPI x CROSS

1284

INF x DPI x CROSS
No effects

652
19
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directly monitored in resource populations using the
same cSNPs.
The described method, although demonstrated in
inbred chicken lines, is applicable to all traits in any
diploid species, and should prove to be a simple method
to identify the majority of genes controlling any complex trait.
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